{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:05:57Z","timestamp":1765667157944},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijcard.2016.06.070","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T19:23:05Z","timestamp":1466882585000},"page":"895-900","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"220","author":[{"given":"Yue","family":"Fei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man Fung","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommy Tsang","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard Man Yung","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.06.070_bb0005","doi-asserted-by":"crossref","first-page":"f6530","DOI":"10.1136\/bmj.f6530","article-title":"Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis","volume":"347","author":"Navarese","year":"2013","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ijcard.2016.06.070_bb0010","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","article-title":"Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern","volume":"115","author":"Camenzind","year":"2007","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ijcard.2016.06.070_bb0015","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1161\/CIR.0b013e31823ba622","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"issue":"37","key":"10.1016\/j.ijcard.2016.06.070_bb0020","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur. Heart J."},{"issue":"16","key":"10.1016\/j.ijcard.2016.06.070_bb0025","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study (PRODIGY) investigators. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomised multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2016.06.070_bb0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomised, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcard.2016.06.070_bb0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2014.11.008","article-title":"6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomised, multicenter ITALIC trial","volume":"65","author":"Gilard","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"20","key":"10.1016\/j.ijcard.2016.06.070_bb0040","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2014.09.008","article-title":"Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomised clinical trial","volume":"64","author":"Colombo","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.ijcard.2016.06.070_bb0045","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2016.06.070_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2012.09.009","article-title":"Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design of a large-scale, randomised, multicenter study","volume":"164","author":"Feres","year":"2012","journal-title":"Am. Heart J."},{"issue":"20","key":"10.1016\/j.ijcard.2016.06.070_bb0055","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/eurheartj\/ehu523","volume":"36","author":"Schulz-Schupke","year":"2015","journal-title":"Eur. Heart J."},{"issue":"15","key":"10.1016\/j.ijcard.2016.06.070_bb0060","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMoa1001266","article-title":"Duration of dual antiplatelet therapy after implantation of drug-eluting stents","volume":"362","author":"Park","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2016.06.070_bb0065","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.113.003303","article-title":"Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomised, controlled trial","volume":"129","author":"Lee","year":"2014","journal-title":"Circulation"},{"issue":"9954","key":"10.1016\/j.ijcard.2016.06.070_bb0070","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(14)60612-7","article-title":"Dual-antiplatelet treatment beyond 1year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial","volume":"384","author":"Collet","year":"2014","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ijcard.2016.06.070_bb0075","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2016.06.070_bb0080","first-page":"365","article-title":"Stopping or continuing clopidogrel 12months after drug-eluting stent placement: the OPTIDUAL randomised trial","volume":"37","author":"Helft","year":"2016","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2016.06.070_bb0085","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.amjcard.2006.02.039","article-title":"Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up","volume":"98","author":"Park","year":"2006","journal-title":"Am. J. Cardiol."},{"issue":"16","key":"10.1016\/j.ijcard.2016.06.070_bb0090","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.0000127105.99982.21","article-title":"Stent thrombosis after successful sirolimus-eluting stent implantation","volume":"109","author":"Jeremias","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ijcard.2016.06.070_bb0095","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jacc.2015.01.024","article-title":"DAPT duration after DES: what is the \u201cmandatory\u201d duration?","volume":"65","author":"Mehran","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.06.070_bb0100","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.amjcard.2014.04.035","article-title":"Meta-analysis of randomised clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stents","volume":"114","author":"El-Hayek","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.070_bb0105","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ijcard.2015.03.073","article-title":"Optimal duration of dual antiplatelet therapy following drug-eluting stents implantation: a meta-analysis of 7 randomised controlled trials","volume":"201","author":"Liou","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2016.06.070_bb0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ccd.25520","article-title":"Shorter (<\/=6months) versus longer (>\/=12months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomised clinical trials. Catheterization and cardiovascular interventions","volume":"85","author":"Pandit","year":"2015","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"24","key":"10.1016\/j.ijcard.2016.06.070_bb0115","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1093\/eurheartj\/ehs318","article-title":"Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomised trials","volume":"33","author":"Cassese","year":"2012","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.ijcard.2016.06.070_bb0120","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents","volume":"48","author":"Pfisterer","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.06.070_bb0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.297.2.joc60179","article-title":"Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation","volume":"297","author":"Eisenstein","year":"2007","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.ijcard.2016.06.070_bb0130","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","article-title":"Predictors of coronary stent thrombosis the Dutch Stent Thrombosis Registry","volume":"53","author":"Van Werkum","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.070_bb0135","doi-asserted-by":"crossref","first-page":"13204","DOI":"10.1038\/srep13204","article-title":"Duration of dual antiplatelet therapy after drug-eluting stent implantation: meta-analysis of large randomised controlled trials","volume":"5","author":"Tsoi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcard.2016.06.070_bb0140","doi-asserted-by":"crossref","first-page":"h1618","DOI":"10.1136\/bmj.h1618","article-title":"Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials","volume":"350","author":"Navarese","year":"2015","journal-title":"BMJ"},{"issue":"9985","key":"10.1016\/j.ijcard.2016.06.070_bb0145","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0140-6736(15)60263-X","article-title":"Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials","volume":"385","author":"Palmerini","year":"2015","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ijcard.2016.06.070_bb0150","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316310762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316310762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:29:27Z","timestamp":1536625767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316310762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":30,"alternative-id":["S0167527316310762"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.070","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}